GINKGO BILOBA BIO - 45 GELULES
Food supplement declared in France, declaration No 2022-8-1563, decision dated 31 August 2022
GINKGO BILOBA BIO - 45 GELULES (LABORATOIRES ILAPHARM) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Ginkgo biloba 240 mg per day, Magnesium, Fibres solubles d'acacia, Son de riz. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- LABORATOIRES ILAPHARM
- Food business operator placing the product on the market
- Laboratoires ILAPHARM SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 gélules
- Directions for use
- Prendre 3 gélules par jour : une le matin, une le midi et une le soir.
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Taking anticoagulants, Taking antidepressants
- Objectives stated by the manufacturer (these are not authorised claims)
- Memory
Declaration 271684, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Ginkgo biloba L. | Feuille | Poudre (de plantes séchées ou broyées) | 240 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Fibres solubles d'acacia | not declared |
| Son de riz | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| magnesium carbonate | Magnesium | 250 mg | 300 mg |
Other ingredients
Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose journalière conseillée. Tenir hors de portée des jeunes enfants. Ne peut remplacer une alimentation variée, équilibrée et un mode de vie sain. À conserver à l’abri de la chaleur et de l’humidité. Consultez votre médecin en cas de prise simultanée d'anticoagulants. Déconseillé en cas de grossesse et d'allaitement et chez les personnes sous traitement antidépresseur.
Regulatory points
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ginkgo biloba L.
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- GINKGO BILOBA BIO - 45 GELULES LABORATOIRES ILAPHARM, declared in 2017, earlier declaration, replaced by the 2022 declaration : different composition: 0 ingredient(s) added, 2 missing
Brand : LABORATOIRES ILAPHARM
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “GINKGO BILOBA BIO - 45 GELULES (LABORATOIRES ILAPHARM): composition and regulation”, https://compoatlas.com/en/supplements/products/271684-ginkgo-biloba-bio-45-gelules, updated 15 November 2026.